SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025612
Filing Date
2020-05-15
Accepted
2020-05-15 06:02:10
Documents
45
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvus-10q_20200331.htm 10-Q 1296284
2 EX-31.1 nvus-ex311_8.htm EX-31.1 11345
3 EX-31.2 nvus-ex312_7.htm EX-31.2 11488
4 EX-32.1 nvus-ex321_9.htm EX-32.1 7482
5 EX-32.2 nvus-ex322_6.htm EX-32.2 7860
  Complete submission text file 0001564590-20-025612.txt   3908517

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvus-20200331.xml EX-101.INS 655977
7 XBRL TAXONOMY EXTENSION SCHEMA nvus-20200331.xsd EX-101.SCH 40650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvus-20200331_cal.xml EX-101.CAL 30409
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvus-20200331_def.xml EX-101.DEF 79446
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20200331_lab.xml EX-101.LAB 259116
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20200331_pre.xml EX-101.PRE 178444
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 20880398
SIC: 2834 Pharmaceutical Preparations